A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer

Abstract Objective Immunotherapy extensively treats advanced non‐small‐cell lung cancer (NSCLC). Although immunotherapy is generally better tolerated than chemotherapy, it can cause multiple immune‐related adverse events (irAEs) involving multiple organs. Checkpoint inhibitor‐related pneumonitis (CI...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yao Zhang, Lincheng Zhang, Shuhui Cao, Yue Wang, Xuxinyi Ling, Yan Zhou, Hua Zhong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-08-01
coleção:	Cancer Medicine
Assuntos:	checkpoint inhibitor‐related pneumonitis (CIP) immunotherapy nomogram non‐small‐cell lung cancer (NSCLC) predict
Acesso em linha:	https://doi.org/10.1002/cam4.6244
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!